MaxCyte

MaxCyte Non-Current Assets

The Non-Current Assets of MaxCyte (MXCT) as of Nov 21, 2026 is -62.30 M USD.

Non-Current Assets

-62.30 MUSD

Last updated:

Non-Current Assets of MaxCyte is 2025 -62.30 M USD. Non-Current Assets of MaxCyte was 2024 - USD. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

MaxCyte Stock analysis

What does MaxCyte do? MaxCyte Inc is a US biotechnology company specializing in the development of platform-based technologies for the next generation of gene and cell therapies. They offer integrated platform technology for drug manufacturing, research, and development. Their proprietary platform technology, Flow ElectroporationTM, allows for efficient transduction of a variety of cells, making it a valuable tool for the production of CAR-T cell therapies. They also offer services for lentiviral production and customized gene therapy production. MaxCyte has secured $50 million in funding for expansion and has formed important partnerships in the industry. They are a leading player in the development of innovative technologies for gene and cell therapy products. MaxCyte is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MaxCyte stock

Non-Current Assets of MaxCyte is -62.30 M USD in 2025.

On Eulerpool you can find the complete historical development of Non-Current Assets MaxCyte since 2006 – with annual values, charts, and detailed analysis.

Non-current assets are long-term resources not expected to be converted to cash within one year, including property, equipment, and long-term investments.

Non-Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Non-Current Assets's MaxCyte historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — MaxCyte

All Key Metrics — MaxCyte